secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0001193125-23-302488
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks raises $50M via pre-funded warrants; cash runway into H2 2027
-----------------------------------------------------------------------

- Gross proceeds of ~$50M from sale of 5,086,521 pre-funded warrants at $9.8299 each.
- Each warrant exercisable at $0.0001/share, with 19.99% beneficial ownership limitation.
- EcoR1 Capital receives board nomination right for one partner until Jan 1, 2026.
- Proceeds to extend cash runway into H2 2027, fund R&D and general corporate purposes.
- Closing expected Dec 28, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312523302488/0001193125-23-302488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312523302488/d647927d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-302488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer